Brief: Rani Therapeutics Reports Fourth Quarter Financial Results

Rani Therapeutics Holdings

22/03/2023 20:26

March 22 (Reuters) - Rani Therapeutics Holdings Inc
 RANI.O :
    * RANI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE
    * ANTICIPATES INITIATING FIRST PHASE 2 CLINICAL STUDY IN
RT-102 IN
2H OF 2023
    * QTRLY NET LOSS PER CLASS A COMMON SHARE ATTRIBUTABLE TO
RANI
THERAPEUTICS HOLDINGS, INC., BASIC AND DILUTED $0.35
    * Q4 EARNINGS PER SHARE VIEW $-0.35 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX42Fzjl 
Further company coverage:  RANI.O 

 ((Reuters.Briefs@thomsonreuters.com;))